(Q37708428)

22 August 2017

Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience (English)

1 reference

22 August 2017

diffuse midline glioma

0 references

8

Leena Ketonen

0 references

author name string

Johannes E Wolff

1

1 reference

22 August 2017

Michael E Rytting

2

1 reference

22 August 2017

Tribhawan S Vats

3

1 reference

22 August 2017

Peter E Zage

4

1 reference

22 August 2017

Joann L Ater

5

1 reference

22 August 2017

Shiao Woo

6

1 reference

22 August 2017

John Kuttesch

7

1 reference

22 August 2017

Leena Ketonen

8

1 reference

22 August 2017

Anita Mahajan

9

1 reference

22 August 2017

language of work or name

1 reference

20 August 2011

1 reference

Journal of Neuro-Oncology

22 August 2017

1 reference

22 August 2017

106

1 reference

22 August 2017

2

1 reference

22 August 2017

391-397

1 reference

Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Cancer inflammation and regulatory T cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Discovering clinical biomarkers of ionizing radiation exposure with serum proteomic analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

High-dose methotrexate prior to simultaneous radiochemotherapy in children with malignant high-grade gliomas.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Inhibition of the arachidonic acid metabolism blocks endothelial cell migration and induces apoptosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Brainstem Gliomas. A 10-year institutional review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Pediatric brain stem gliomas: a review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

High-dose carmustine for high-grade gliomas in childhood

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D Pilot study

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Treatment options in childhood pontine gliomas

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Microglia cyclooxygenase-2 activity in experimental gliomas: possible role in cerebral edema formation.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3990187

Pediatric brain stem gliomas: an update

1 September 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Young age may predict a better outcome for children with diffuse pontine glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Paediatric brainstem gliomas: prognostic factors and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Conventional MRI cannot predict survival in childhood diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

DTI fiber tracking to differentiate demyelinating diseases from diffuse brain stem glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Diffusion tensor imaging and white matter tractography in patients with brainstem lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Diffuse brainstem gliomas in children: should we or shouldn't we biopsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic - perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Treatment of paediatric pontine glioma with oral trophosphamide and etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Multinomial regression models based on continuation ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Nimotuzumab for pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Stereotactic biopsy for brainstem tumors in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

Advances toward an understanding of brainstem gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0677-3

10.1007/S11060-011-0677-3

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

22 August 2017

PubMed publication ID

21858608

1 reference